Asset
APVO-414
APTEVO THERAPEUTICS INC. COMMON STOCK
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT02262910 | phase1 | completed | 2015-01-01 | 2018-12-01 | Aptevo Therapeutics | Study of ES414 in Metastatic Castration-Resistant Prostate Cancer |
FDA applications (0)
This company has no applications containing this asset.